A synthetic peptide for use as a blocking control in assays to test for specificity of XAGE2 antibody, Alternative Names: XAGE2 control peptide, XAGE2 antibody Blocking Peptide, Anti-XAGE2 Blocking Peptide, X antigen family, member 2 Blocking Peptide, CT12.2 Blocking Peptide, GAGED3 Blocking Peptide, XAGE-2 Blocking Peptide, XAGE2B Blocking Peptide, XAGE2, XAGE-2, XAGE 2, XAGE-2 Blocking Peptide, XAGE 2 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
XAGE2
(X Antigen Family, Member 2 (XAGE2))
Hintergrund
This gene is a member of the XAGE subfamily, which belongs to the GAGE family. The GAGE genes are expressed in a variety of tumors and in some fetal and reproductive tissues. This gene is strongly expressed in normal testis, and in Ewing's sarcoma, rhabdomyosarcoma, a breast cancer and a germ cell tumor. The protein encoded by this gene shares a sequence similarity with other GAGE/PAGE proteins. Because of the expression pattern and the sequence similarity, this protein also belongs to a family of CT (cancer-testis) antigens.